Earningsreport

Q3/2023 9/30/2023 EPS -0.110 ZacksConsensus -0.110 ActVsEst 0.000 - In-Line

Pieris Pharmaceuticals, Inc.  (PIRS) 
NASDAQ:AMEX Investor Relations: ir.pieris.com